Tag: antibody
CanSinoBIO CSO Shares the Latest Results of the Company’s Globally Innovative Pneumococcal Vaccine
HONG KONG, Apr 26, 2024 - (ACN Newswire) - On April 20, the 2024 National Vaccines and Health Conference organized by the Chinese Preventive Medicine...
Breaking News
Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S.
SIMLANDI is the first biosimilar approval under the strategic...
Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report
Clinical development productivity rose in 2023, primarily due to an improvement in the composite success rate, a function of phases successfully completed in the...
Passage of the Amendment to the Advanced Regenerative Biotech Act a Positive Catalyst for Korean and Japanese Cell Therapy Companies
Legislation Puts Renewed Focus on Next-Generation NK Cell Therapies
New York, Feb 7, 2024 - (Plato Data) - On Thursday February 2, 2024, the bio...
DNA Nanobots Closes Pre-seed Investment Round to Grow BioPharma Partner Program
Platform company uses antibody-targeted DNA nanoparticles to deliver a wide range of therapeutic payloads to desired tissue.
COLUMBUS, Ohio–(BUSINESS WIRE)–#RNA–DNA Nanobots, a leader in the...
Focused ultrasound plus plaque-reducing drugs could slow Alzheimer’s progression – Physics World
<a href="https://platoblockchain.net/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-fancybox data-src="https://platoblockchain.net/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-caption="Deliver the drugs Researchers at the West Virginia University Rockefeller Neuroscience Institute, shown in the MRI...
Development of Prediction Model for Brain Amyloid-Beta Accumulation Using Wristband Sensor
TOKYO, Dec 29, 2023 - (JCN Newswire) - Oita University and Eisai Co., Ltd. (Eisai) hereby announce the development of the world's first machine...
USA Solid Tumor Therapeutics Market Outlook to 2028 – Field of Oncology is Moving Towards more Personalized Treatment – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Solid Tumor Therapeutics Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering.
The USA Solid Tumor Therapeutics Market refers to...
This Week’s Awesome Tech Stories From Around the Web (Through December 16)
Google DeepMind Used a Large Language Model to Solve an Unsolvable Math ProblemWill Douglas Heaven | MIT Technology Review“In a paper published in Nature...
Ultrasound innovations enable pain-free vaccination, monitor muscle dynamics in real time – Physics World
The Acoustics 2023 Sydney conference, co-hosted by the Acoustical Society of America and the Australian...
“LEQEMBI Intravenous Infusion”Lecanemab) for the Treatment of Alzheimer’s Disease to be Launched in Japan on December 20
TOKYO and CAMBRIDGE, Mass., Dec 14, 2023 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated...
SimBioSys Presents New Data for Breast Cancer Personalized Medicine Platforms at the 46th Annual San Antonio Breast Cancer Symposium
CHICAGO–(BUSINESS WIRE)–SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and data science to redefine precision medicine for cancer...
IPA Announces Closing of $1.265 Million Public Offering of Common Shares
VICTORIA, British Columbia–(BUSINESS WIRE)–$IPA #AI–ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“ImmunoPrecise” or “IPA” or the “Company”), today announced the closing of its $1.265 million underwritten...
Latest Intelligence
